Details
 

September 24, 2020
12:00PM - 1:00PM

MSHO Corporate Sponsor Zoom Meetings

Genomic Health, ImmunoMedics, Meijer Specialty Pharmacy, Pfizer, Takeda Oncology

Zoom Meeting

Do you miss having your favorite pharma reps visit your office? MSHO will be hosting a series of Zoom lunch meetings with some of our corporate sponsors. Join your colleagues and pharma friends for 25 minutes of education and seeing each others' smiling faces!

Registration has now closed. 

12:00 pm - 12:25 pm Meetings:

  • ImmunoMedics
    • Overview: Metastatic triple negative breast cancer, FDA approved ADC Therapy. 
  • Meijer Specialty Pharmacy
    • Overview: MSP services to practices and patient discussion focusing on our service model for office and patients.
  • Pfizer
    • Overview: Pfizer Update on Clinical Data and Resources

12:35 pm - 1:00 pm Meetings:

  • Exact Sciences
    • Overview: Oncotype DX, Recurrence Score for Invasive Breast Cancer, Oncotype DX AR-V7 for metastatic Castrate Resistant Prostate Cancer 
  • Takeda Oncology
    • Overview: Takeda Oncology Update

For questions regarding this event, please contact MSHO at 248-385-5464 or email kblazevski@msho.org.

Printer-Friendly Version


Add to Calendar aCLuDhaqizCaPxAftmqF167204 09/24/2020 12:00 PM 09/24/2020 01:00 PM false MSHO Corporate Sponsor Zoom Meetings Do you miss having your favorite pharma reps visit your office? MSHO will be hosting a series of Zoom lunch meetings with some of our corporate sponsors. Join your colleagues and pharma friends for 25 minutes of education and seeing each others' smiling faces! Registration has now closed.  12:00 pm - 12:25 pm Meetings: ImmunoMedics Overview: Metastatic triple negative breast cancer, FDA approved ADC Therapy.  Meijer Specialty Pharmacy Overview: MSP services to practices and patient discussion focusing on our service model for office and patients. Pfizer Overview: Pfizer Update on Clinical Data and Resources 12:35 pm - 1:00 pm Meetings: Exact Sciences Overview: Oncotype DX, Recurrence Score for Invasive Breast Cancer, Oncotype DX AR-V7 for metastatic Castrate Resistant Prostate Cancer  Takeda Oncology Overview: Takeda Oncology Update For questions regarding this event, please contact MSHO at 248-385-5464 or email kblazevski@msho.org. Zoom Meeting

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it! 
Report Broken Link